Narin Yasar

Narin Yasar has extensive experience in the pharmaceutical and biotechnology industries, having held various leadership roles across prominent companies. At GSK, from May 2013 to January 2016, Narin served as Business Unit Head for Critical Diseases, establishing a new business unit and managing sales and marketing strategies. Previous roles include Marketing and Sales Director at Cegedim, Brand Access Manager at Novartis, and a series of positions at Servier Pharmaceuticals. Narin's expertise encompasses market access, governmental affairs, and value proposition development, currently serving as Director of Global Oncology Market Access and Pricing at Merck since June 2024. Narin's educational background includes a Bachelor of Engineering from Boğaziçi University, an Executive MBA from Rotterdam School of Management, and a certificate in Health Economics and Outcomes Research from the University of Washington.